课题基金 / 基金详情

Role of connective tissue growth factor (CTGF) in association with systemic sclerosis

Role of connective tissue growth factor (CTGF) in association with systemic sclerosis
结缔组织生长因子(CTGF)与系统性硬化症相关的作用
批准号:
10670785
负责人:
TAKEHARA Kazuhiko
金额:
$2.05万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 1999

项目摘要

项目成果

TAKEHARA Kazuhiko的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In these studies, we investigated the role of CTGF, namely inter action with TGF-β in TGF-β induced skin fibrosis model of newborn mice.TGF-β solely induced fibrosis disappears with 3 day peak, although when CTGF was injected simultaneously or consecutively, combination of TGF-β and CTGF induces irreversible fibrosis.Above observations strongly support our hypothesis that TGF-β induces skin fibrosis and CTGF acts to maintain this fibrosis. In addition, we tried to block this fibrosis using anti- CTGF neutralizing antibody, we conformed partial suppression. We are going to screen more potent neutralizing antibody and antisense of DNA.We measured serum CTGF levels of systemic sclerosis using increased cases, we found elevated levels of CTGF the patients and the levels of CTGF was statistically correlated with severity of skin sclerosis and pulmonary fibrosis. Thus, we found strong correlation between CTGF and systemic sclerosis, which is a representative fibrotic disorder.In the future, we use our skin sclerosis mice model by TGF-β and CTGF to screen anti-scleroderma drugs.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
Sato S, Nagaoka T, Hasegawa M, et al: "Serum levels of CTGF are elevated in patients with systemic sclerosis : Association with the extent of skin sclerosis and the severity of pulmonary fibrosis"J Rheumatol. 27. 149-154 (2000)
Sato S、Nagaoka T、Hasekawa M 等人:“系统性硬化症患者的血清 CTGF 水平升高:与皮肤硬化程度和肺纤维化严重程度相关”J Rheumatol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Shinozaki M, Kawara S, Hayashi N, Kakinuma T, Igarashi A, Takehara K: "Induction of subcutaneous fibrosis in newborn mice by transforming growth Factor β-simultaneous application with basic fibroblast growth factor causes persistent fibrosis"Biochem Bioph
Shinozaki M、Kawara S、Hayashi N、Kakinuma T、Igarashi A、Takehara K:“通过转化生长因子 β 诱导新生小鼠皮下纤维化 - 同时应用碱性成纤维细胞生长因子会导致持续性纤维化”Biochem Bioph
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
M.Hasegawa, S.Sato, K.Kikuchi, K.Takehara: "Antigen specificity of antihistone antibodies in systemic scierosis" Annals of the Rheumatic Diseases. 57(8). 470-475 (1998)
M.Hasekawa、S.Sato、K.Kikuchi、K.Takehara:“系统性硬化症中抗组蛋白抗体的抗原特异性”风湿病年鉴。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Mori T, Kawara S, Shinozaki M, Hayashi N, Kakinuma T, Igarashi A, Takigawa M, Nakanishi T, Takehara K: "Role and interaction of connective tissue growth factor with transforming growth factor-β in persistent fibrosis : A mouse fibrosis model"J Cell Physio
Mori T、Kawara S、Shinozaki M、Hayashi N、Kakinuma T、Igarashi A、Takikawa M、Nakanishi T、Takehara K:“结缔组织生长因子与转化生长因子-β 在持续性纤维化中的作用和相互作用:小鼠纤维化模型《细胞生理学杂志》
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
7
    The inhibition by anti-CTGF antibody produced by the DNA immunization method in the cytokine induced skin fibrosis model mice
    • 批准号:
      18591240
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.49万
    • 财政年份:
      2006
    • 负责人:
      TAKEHARA Kazuhiko
    • 依托单位:
    Study of the mechanism of skin fibrosis by utilizing transgenic mice : A mouse scieroderma model
    • 批准号:
      14570801
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.43万
    • 财政年份:
      2002
    • 负责人:
      TAKEHARA Kazuhiko
    • 依托单位:
    国内基金
    海外基金
    基于人源神经肌肉类器官探究 CTGF 在肌萎缩侧索硬化症中抗纤维化作用的分子机制
    • 批准号:
      ZCLMRY26H0901
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      张灏
    • 依托单位:
    Hippo-CTGF调控细胞增殖凋亡迁移在先天性小耳畸形发生中的作用和机制研究
    骨肉瘤细胞源性外泌体circHIPK3竞争性抑制microRNA-132-3p上调CTGF促进骨肉瘤肺转移的机制研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      朱迎春
    • 依托单位:
    TRIM11通过泛素化降解LHX6促进CTGF分泌来诱导肝癌骨转移及骨破坏的作用机制研究
    • 批准号:
      2024Y9027
    • 项目类别:
      省市级项目
    • 资助金额:
      15.0万元
    • 批准年份:
      2024
    • 负责人:
      吴俊艺
    • 依托单位: